Publications in OpenAlex of which a co-author is affiliated to this organization
All publications | By field | By subfield
All publications [Next]
| Title | DOI |
|---|---|
| https://doi.org/10.1016/j.esmoop.2025.104374 | 61MO Perceptions of healthcare professionals and regulators on the use of real-world data as external comparators in late-stage oncology single-arm trials |
| https://doi.org/10.1182/hem.v22.4.2025415 | Unifying Threads: ASH and EHA Collaborate to Support Hematologists |
| https://doi.org/10.1016/j.jcyt.2025.09.007 | Call for preserving specialized knowledge and contributions of the CAT to advancing ATMPs in Europe |
| https://doi.org/10.1182/bloodadvances.2025017081 | Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in Europe |
| https://doi.org/10.19044/esj.2025.v21n26p45 | EU market in Sight, Russian at the Gate: Three Decades of Aspiration and Resistance |
| https://doi.org/10.1007/978-3-031-93365-3_5 | Digitalization of the Global Economy and the OECD Reform of MNE’s Corporate Income Tax: Background, Challenges, and Issues |
| https://doi.org/10.1002/hem3.70243 | Operational burden and fragmented implementation in CAR T‐cell therapy: Insights from a multinational survey by the GoCART Coalition and the JACIE Quality Managers Committee |
| https://doi.org/10.1111/conl.13158 | Hybrids Along a Natural‐Anthropogenic Gradient: Improving Policy and Management Across All Levels of Biodiversity |
| https://doi.org/10.1007/s13278-025-01550-8 | Assessing mobile instant messenger networks with donated data |
| https://doi.org/10.1016/j.jcpo.2025.100700 | Accelerating cancer treatment optimisation: A multistakeholder roadmap from the Cancer Medicines Forum |
| https://doi.org/10.1002/cpt.70213 | Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real‐World Data |
| https://doi.org/10.1111/jhn.70219 | Exploring Dietitians' Needs and Challenges in Food Data Literacy Training: A Mixed Methods Study |
| https://doi.org/10.1002/hem3.70306 | The European CAR‐T map—Current status and future directions to improve access to CAR T‐cell therapy for hematologic malignancies |